Kano Therapeutics (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- August 12, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,100,000
Company Info
- Company Description
- Kano Therapeutics develops single-stranded DNA for targeted gene correction.
- Market
- Cell and Gene Therapies
- Location
- Cambridge, MA, USA
- Coinvestors
- MetaPlanet Holdings, Taihill Venture, The Engine, Vsquared Ventures